Epigentic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer.
By: Etmar Bulk, Anne-Sophie Ay, Mehdi Hammadi, Halima Ouadid-Ahidouch, Sonja Schelhaas, Antje Hascher, Christian Rohde, Nils H Thoennissen, Rainer Wiewrodt, Eva Schmidt, Alessandro Marra, Ludger Hillejan, Andreas H Jacobs, Hans-Ulrich Klein, Martin Dugas, Wolfgang E Berdel, Carsten Müller-Tidow, Albrecht Schwab

Institute of Physiology II and Department of Medicine, Hematology, Oncology and Pneumology, , University of Muenster, Germany.
2014-7-21; doi: 10.1002/ijc.29490
Abstract

Epigenomic changes are an important feature of malignant tumors. How tumor aggressiveness is affected by DNA methylation of specific loci is largely unexplored. In genome wide DNA methylation analyses we identified the KCa 3.1 channel gene (KCNN4) promoter to be hypomethylated in an aggressive non-small cell lung carcinoma (NSCLC) cell line and in patient samples. Accordingly, KCa 3.1 expression was increased in more aggressive NSCLC cells. Both findings were strong predictors for poor prognosis in lung adenocarcinoma. Increased KCa 3.1 expression was associated with aggressive features of NSCLC cells. Proliferation and migration of pro-metastatic NSCLC cells depended on KCa 3.1 activity. Mechanistically, elevated KCa 3.1 expression hyperpolarized the membrane potential thereby augmenting the driving force for Ca(2+) influx. KCa 3.1 blockade strongly reduced the growth of xenografted NSCLC cells in mice as measured by PET-CT. Thus, loss of DNA methylation of the KCNN4 promoter and increased KCa 3.1 channel expression and function are mechanistically linked to poor survival of NSCLC patients. This article is protected by copyright. All rights reserved.



Copyright © 2015 UICC.

PMID:25704182






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements